Gaucher′s disease
Gaucher′s disease (GD) is the most common amongst the various disorders classified under the lysosomal storage disorders. GD is a model for applications of molecular medicine to clinical delineation, diagnosis, and treatment. The multiorgan and varied presentation of the disease makes it a challenge...
Main Authors: | Vijay Bohra, Velu Nair |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2011;volume=15;issue=3;spage=182;epage=186;aulast=Bohra |
Similar Items
-
Hemorrhagic Aspects of Gaucher Disease
by: Hanna Rsenbaum
Published: (2014-10-01) -
EVALUATION OF ENZYME REPLACEMENT THERAPY EFFECTIVENESS IN CHILDREN WITH GAUCHER’S DISEASE ACCORDING TO THE INTERNATIONAL STUDIES
by: O. S. Gundobina, et al.
Published: (2014-05-01) -
Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the International Collaborative Gaucher Group Gaucher Registry
by: Jennifer Ibrahim, et al.
Published: (2016-09-01) -
The International Collaborative Gaucher Group GRAF (Gaucher Risk Assessment for Fracture) score: a composite risk score for assessing adult fracture risk in imiglucerase-treated Gaucher disease type 1 patients
by: Patrick Deegan, et al.
Published: (2021-02-01) -
Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease
by: Ari Zimran, et al.
Published: (2018-02-01)